The people
Open roles via the TechTO Job Board
Working at F-Prime Capital
Browse open roles across the community on the TechTO Job Board — Canada’s most connected tech network. F-Prime Capital’s roles show up here whenever they post.
Open roles on the TechTO Job Board ↗Or their own careers page: fprimecapital.com/careers ↗Jobs live on jobs.techto.org — the only structured source. We link to it rather than scraping career sites, so the board is always the source of truth.
On the TechTO stage
Every talk is searchable — ask the archive about F-Prime Capital ↗
About
F-Prime Capital is Fidelity's venture capital arm. Its roots are in biotech — it was formerly Fidelity Biosciences — and it still invests heavily in therapeutics, medical devices and healthcare delivery, but since the mid-2010s it has also run a technology fund covering developer tools, fintech and software for the lab and R&D. Operating partner Shervin Ghaemmaghami joined in 2012 to help start that technology fund. F-Prime led BenchSci's US$22-million Series B in 2020, taking a board seat, and in 2021 he and BenchSci co-founder Liran Belenzon walked through how the deal came together on TechTO's Founders & Funding podcast.
Backers
The venture arm of Fidelity; it is not itself venture-backed.
Quick answers
What is F-Prime Capital?
The venture capital arm of Fidelity, investing in healthcare and technology. Its healthcare practice was formerly Fidelity Biosciences; its technology practice was formerly part of Devonshire Investors.
What is its connection to Canadian tech?
It led the US$22-million Series B into Toronto's BenchSci in 2020, with senior vice-president Shervin Ghaemmaghami joining the board. F-Prime later signed a commercial agreement to use BenchSci's ASCEND platform in its own research.
Who spoke for F-Prime at TechTO?
Shervin Ghaemmaghami, on the Founders & Funding podcast in June 2021, alongside BenchSci's Liran Belenzon.